# Clinical Trial of Huoluo Pills Combined With Iguratimod Tablets in the Treatment of Rheumatoid Arthritis

> **NCT07115641** · NA · NOT_YET_RECRUITING · sponsor: **Wangjing Hospital, China Academy of Chinese Medical Sciences** · enrollment: 240 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Huoluo Pills
- **DRUG:** Iguratimod Tablets

## Key facts

- **NCT ID:** NCT07115641
- **Lead sponsor:** Wangjing Hospital, China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-11
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-08-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07115641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07115641, "Clinical Trial of Huoluo Pills Combined With Iguratimod Tablets in the Treatment of Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07115641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*